
|Videos|March 8, 2022
2022 ASCO GU Lookback: Dr. Kukreja on key kidney and bladder cancer findings
Author(s)Urology Times staff
Janet Kukreja, MD, recaps 5 presentations from the 2022 Genitourinary Cancers Symposium.
Advertisement
Episodes in this series
In this video, Urology Times® Editorial Council member Janet Kukreja, MD, discusses abstracts on urothelial carcinoma, renal cell carcinoma, and muscle-invasive bladder cancer that were presented at the 2022 Genitourinary Cancers Symposium. Kukreja is an assistant professor of urology at the University of Colorado Urology in Aurora.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
4
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
5














